Andreas Halvorsen acquired 12.3M Biomarin Pharmaceutical - Registered Shares shares worth $725M. That's 2.04% of their equity portfolio (14th largest holding). The investor owns 6.48% of the outstanding Biomarin Pharmaceutical - Registered Shares stock. The first Biomarin Pharmaceutical - Registered Shares trade was made in Q1 2016. Since then Andreas Halvorsen bought shares 22 more times and sold shares on nine occasions. The investor's estimated purchase price is $1.01B, resulting in a loss of 28%.